vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Soho House & Co Inc. (SHCO). Click either name above to swap in a different company.

Soho House & Co Inc. is the larger business by last-quarter revenue ($370.8M vs $284.0M, roughly 1.3× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs -5.0%, a 101.4% gap on every dollar of revenue. On growth, Soho House & Co Inc. posted the faster year-over-year revenue change (11.2% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 13.5%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Soho House is an international private members’ club with a focus on the media, arts and fashion industries.

ACAD vs SHCO — Head-to-Head

Bigger by revenue
SHCO
SHCO
1.3× larger
SHCO
$370.8M
$284.0M
ACAD
Growing faster (revenue YoY)
SHCO
SHCO
+1.8% gap
SHCO
11.2%
9.4%
ACAD
Higher net margin
ACAD
ACAD
101.4% more per $
ACAD
96.3%
-5.0%
SHCO
Faster 2-yr revenue CAGR
ACAD
ACAD
Annualised
ACAD
17.5%
13.5%
SHCO

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
ACAD
ACAD
SHCO
SHCO
Revenue
$284.0M
$370.8M
Net Profit
$273.6M
$-18.7M
Gross Margin
90.8%
Operating Margin
6.1%
-1.6%
Net Margin
96.3%
-5.0%
Revenue YoY
9.4%
11.2%
Net Profit YoY
90.3%
-10790.3%
EPS (diluted)
$1.61
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
SHCO
SHCO
Q4 25
$284.0M
Q3 25
$278.6M
$370.8M
Q2 25
$264.6M
$329.8M
Q1 25
$244.3M
$282.9M
Q4 24
$259.6M
$305.6M
Q3 24
$250.4M
$333.4M
Q2 24
$242.0M
$302.9M
Q1 24
$205.8M
$261.9M
Net Profit
ACAD
ACAD
SHCO
SHCO
Q4 25
$273.6M
Q3 25
$71.8M
$-18.7M
Q2 25
$26.7M
$24.9M
Q1 25
$19.0M
$8.2M
Q4 24
$143.7M
$-91.7M
Q3 24
$32.8M
$175.0K
Q2 24
$33.4M
$-29.9M
Q1 24
$16.6M
$-41.6M
Gross Margin
ACAD
ACAD
SHCO
SHCO
Q4 25
90.8%
Q3 25
92.2%
Q2 25
92.2%
Q1 25
91.7%
Q4 24
91.6%
Q3 24
92.5%
Q2 24
92.5%
Q1 24
88.8%
Operating Margin
ACAD
ACAD
SHCO
SHCO
Q4 25
6.1%
Q3 25
12.8%
-1.6%
Q2 25
12.2%
18.1%
Q1 25
7.9%
12.3%
Q4 24
59.1%
-23.1%
Q3 24
12.6%
11.4%
Q2 24
12.6%
-4.3%
Q1 24
7.4%
-9.3%
Net Margin
ACAD
ACAD
SHCO
SHCO
Q4 25
96.3%
Q3 25
25.8%
-5.0%
Q2 25
10.1%
7.5%
Q1 25
7.8%
2.9%
Q4 24
55.4%
-30.0%
Q3 24
13.1%
0.1%
Q2 24
13.8%
-9.9%
Q1 24
8.0%
-15.9%
EPS (diluted)
ACAD
ACAD
SHCO
SHCO
Q4 25
$1.61
Q3 25
$0.42
$-0.10
Q2 25
$0.16
$0.13
Q1 25
$0.11
$0.04
Q4 24
$0.86
$-0.48
Q3 24
$0.20
$0.00
Q2 24
$0.20
$-0.15
Q1 24
$0.10
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
SHCO
SHCO
Cash + ST InvestmentsLiquidity on hand
$177.7M
$142.5M
Total DebtLower is stronger
$735.8M
Stockholders' EquityBook value
$1.2B
$-351.6M
Total Assets
$1.6B
$2.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
SHCO
SHCO
Q4 25
$177.7M
Q3 25
$258.0M
$142.5M
Q2 25
$253.6M
$150.3M
Q1 25
$217.7M
$150.1M
Q4 24
$319.6M
$152.7M
Q3 24
$155.1M
$142.8M
Q2 24
$177.1M
$148.5M
Q1 24
$204.7M
$139.8M
Total Debt
ACAD
ACAD
SHCO
SHCO
Q4 25
Q3 25
$735.8M
Q2 25
$729.8M
Q1 25
$705.1M
Q4 24
$691.5M
Q3 24
$694.8M
Q2 24
$682.1M
Q1 24
$671.7M
Stockholders' Equity
ACAD
ACAD
SHCO
SHCO
Q4 25
$1.2B
Q3 25
$917.3M
$-351.6M
Q2 25
$822.4M
$-348.6M
Q1 25
$765.2M
$-340.1M
Q4 24
$732.8M
$-335.1M
Q3 24
$577.2M
$-279.4M
Q2 24
$516.7M
$-231.7M
Q1 24
$464.0M
$-193.0M
Total Assets
ACAD
ACAD
SHCO
SHCO
Q4 25
$1.6B
Q3 25
$1.3B
$2.7B
Q2 25
$1.2B
$2.6B
Q1 25
$1.1B
$2.5B
Q4 24
$1.2B
$2.4B
Q3 24
$976.9M
$2.6B
Q2 24
$914.1M
$2.6B
Q1 24
$855.1M
$2.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
SHCO
SHCO
Operating Cash FlowLast quarter
$-48.7M
$34.9M
Free Cash FlowOCF − Capex
$3.5M
FCF MarginFCF / Revenue
0.9%
Capex IntensityCapex / Revenue
8.5%
Cash ConversionOCF / Net Profit
-0.18×
TTM Free Cash FlowTrailing 4 quarters
$41.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
SHCO
SHCO
Q4 25
$-48.7M
Q3 25
$74.3M
$34.9M
Q2 25
$64.0M
$41.0M
Q1 25
$20.3M
$22.8M
Q4 24
$40.4M
$26.9M
Q3 24
$63.2M
$20.6M
Q2 24
$25.0M
$36.0M
Q1 24
$29.1M
$6.2M
Free Cash Flow
ACAD
ACAD
SHCO
SHCO
Q4 25
Q3 25
$73.9M
$3.5M
Q2 25
$12.4M
Q1 25
$7.5M
Q4 24
$18.5M
Q3 24
$63.2M
$10.3M
Q2 24
$10.2M
Q1 24
$-13.5M
FCF Margin
ACAD
ACAD
SHCO
SHCO
Q4 25
Q3 25
26.5%
0.9%
Q2 25
3.8%
Q1 25
2.7%
Q4 24
6.1%
Q3 24
25.2%
3.1%
Q2 24
3.4%
Q1 24
-5.2%
Capex Intensity
ACAD
ACAD
SHCO
SHCO
Q4 25
Q3 25
0.1%
8.5%
Q2 25
8.7%
Q1 25
5.4%
Q4 24
2.7%
Q3 24
0.0%
3.1%
Q2 24
8.5%
Q1 24
7.5%
Cash Conversion
ACAD
ACAD
SHCO
SHCO
Q4 25
-0.18×
Q3 25
1.03×
Q2 25
2.40×
1.65×
Q1 25
1.07×
2.79×
Q4 24
0.28×
Q3 24
1.93×
117.70×
Q2 24
0.75×
Q1 24
1.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Nuplazid$174.4M61%
Daybue$109.6M39%

SHCO
SHCO

Membership$122.7M33%
Other$122.0M33%
Membership Revenue$58.5M16%
Other Revenue$28.5M8%
Equity Method Investment Nonconsolidated Investee Or Group Of Investees$24.8M7%
Elimination Of Equity Accounted Revenue$13.4M4%
Related Party$2.0M1%
Soho House$1.0M0%

Related Comparisons